Current Problems in Cardiology
Volume 31, Issue 2 , Pages 128-168 , February 2006

Contrast-Enhanced Cardiac Magnetic Resonance in the Evaluation of Myocardial Infarction and Myocardial Viability in Patients with Ischemic Heart Disease

References 

  1. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994;90:2645-57.0
  2. Muhlbaier LH , Pryor DB , Rankin JS , et al.  Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease: 20 years of follow-up . Circulation . 1992;86(suppl II): II-198-204
  3. Alderman EL , Fischer P , Litwin GC , et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS) . Circulation . 1983;68:785–795
  4. Rahimtoola SH . Coronary bypass surgery for chronic angina—1981: a perspective . Circulation . 1982;65:225–241
  5. Braunwald E , Rutherford J . Reversible ischemic left ventricular dysfunction: evidence of the “hibernating myocardium” . J Am Coll Cardiol . 1986;8:1467–1470
  6. Rahimtoola SH . The hibernating myocardium . Am Heart J . 1989;117:211–213
  7. Dilsizian V , Bonow RO . Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium . Circulation . 1993;87:1–20
  8. Heusch G , Schulz R , Rahimtoola SH . Myocardial hibernation: a delicate balance . Am J Physiol Heart Circ Physiol . 2005;288:H984–H999
  9. Bonow RO . Identification of viable myocardium . Circulation . 1996;94:2674–2680
  10. Allman KC , Shaw LJ , Hachamovitch R , et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis . J Am Coll Cardiol . 2002;39:1151–1158
  11. Bonow RO . Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction . J Am Coll Cardiol . 2002;39:1159–1162
  12. Gould KL . Myocardial viability (What does it mean and how to measure it?) . Circulation . 1991;83:333–335
  13. Rehwald W , Fieno DS , Chen EL , et al.  Myocardial magnetic resonance imaging contrast agent concentration after reversible and irreversible ischemic injury . Circulation . 2002;105:224–229
  14. Kim RJ , Choi KM , Judd RM . Assessment of myocardial viability by contrast enhancement . In:  Higgins CB ,  De Roos A editor. Cardiovascular MRI and MRA . Philadelphia, PA: Lippincott Williams & Wilkins; 2003;p. 209–237
  15. Brasch RC , Weinmann HJ , Wesbey GE . Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex . AJR Am J Roentgenol . 1984;142:625–630
  16. Saeed M , Lund G , Wendland MF , et al.  Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media . Circulation . 2001;103:871–876
  17. Kim RJ , Fieno DS , Parrish TB , et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile dysfunction . Circulation . 1999;100:1992–2002
  18. Kim RJ , Chen EL , Lima JAC , et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction . Circulation . 1996;94:3318–3326
  19. Amado LC , Gerber BL , Gupta SN , et al.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model . J Am Coll Cardiol . 2004;44:2383–2389
  20. Choi KM , Kim RJ , Gubernikoff G , et al.  Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function . Circulation . 2001;104:1101–1107
  21. Rogers WJ , Kramer CM , Geskin G , et al.  Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction . Circulation. . 1999;99:744–750
  22. Kramer CM , Rogers WJ , Mankad S , et al.  Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction . J Am Coll Cardiol . 2000;36:1835–1840
  23. Simonetti OP , Kim RJ , Fieno DS , et al.  An improved MR imaging technique for the visualization of myocardial infarction . Radiology . 2001;18:215–223
  24. Oshinski JN , Yang Z , Jones JR , et al.  Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging . Circulation . 2001;104:2838–2842
  25. Mahrholdt H , Wagner A , Holly TA , et al.  Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging . Circulation . 2002;106:2322–2327
  26. Judd RM , Kim RJ . Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging . Circulation . 2002;106:e6
  27. Kim RJ , Wu E , Rafael A , et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction . N Engl J Med . 2000;343:1445–1453
  28. Hillenbrand HB , Kim RJ , Parker MA , et al.  Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging . Circulation . 2000;102:1678–1683
  29. Cerqueira MD , Weissman NJ , Dilsizian V , et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association . Circulation . 2002;105:539–542
  30. Budoff MJ, Cohen MC, Garcia MJ, et al. ACCF/AHA clinical competency statement on cardiac imaging with computed tomography and magnetic resonance. J Am Coll Cardiol 2005;46:383-402.
  31. Lieberman AN , Weiss JL , Jugdutt BI , et al.  Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog . Circulation . 1981;4:739–746
  32. Force T , Kemper A , Perkins L , et al.  Overestimation of infarct size by quantitative two-dimensional echocardiography: the role of tethering and of analytical procedures . Circulation . 1986;73:1360–1368
  33. Sakai K , Watanabe K , Millard RW . Defining the mechanical border zone: a study in the pig heart . Am J Physiol . 1985;249:H88–H94
  34. Weiss JL , Bulkley BH , Hutchins GM , et al.  Two dimensional echocardiography recognition of myocardial injury in man: comparison with postmortem studies . Circulation . 1981;63:401–408
  35. Myers JH , Stirling MC , Choy M , et al.  Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography . Circulation . 1986;74:164–172
  36. Homans DC , Pavek T , Laxson DD , et al.  Recovery of transmural and subepicardial wall thickening after subendocardial infarction . J Am Coll Cardiol . 1994;24:1109–1116
  37. Mahrholdt H , Wagner A , Parker M , et al.  Relationship of contractile dysfunction to transmural extent of infarction in patients with chronic coronary artery disease . J Am Coll Cardiol . 2003;42:505–512
  38. Gibbons RJ , Miller TD , Christian TF . Infarct size measured by single photon emission computed tomographic images with (99m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction . Circulation . 2000;101:101–108
  39. Gibbons RJ , Valeti US , Araoz PA , et al.  The quantification of infarct size . J Am Coll Cardiol . 2004;44:1533–1542
  40. Kitagawa K , Sakuma H , Hirano T , et al.  Acute myocardial infarction: myocardial viability assessment in patients early thereafter comparison of constrast-enhanced MR imaging with resting (201)Tl SPECT (Single photon emission computed tomography) . Radiology . 2003;226:138–144
  41. Klein C , Nekolla SG , Bengel FM , et al.  Assessment of myocardial viability with contrast-enhance magnetic resonance imaging: comparison with positron emission tomography . Circulation . 2002;105:162–167
  42. Wagner A , Mahrholdt H , Holly TA , et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study . Lancet . 2003;361:374–379
  43. Wu E , Judd RM , Vargas JD , et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction . Lancet . 2001;357:21–28
  44. Moon JCC, Perez De Arenaza D, Elkington AG, et al. The pathophysiological basis of Q-wave and non-Q wave myocardial infarction. J Am Coll Cardiol 2004;44:554-60.
  45. Arai AE , Hirsch GA . Q-wave and non-Q-wave myocardial infarction through the eyes of magnetic resonance imaging . J Am Coll Cardiol . 2004;44:561–563
  46. Yang H , Pu M , Rodriguez D , et al.  Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography . J Am Coll Cardiol . 2004;43:592–598
  47. Ingkanisorn WP , Rhoads KL , Aletras AH , et al.  Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction . J Am Coll Cardiol . 2004;43:2253–2259
  48. Bello D , Fieno DS , Kim RJ , et al.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia . J Am Coll Cardiol . 2005;45:1104–1108
  49. Fedele F , Montesano T , Ferro-Luzzi M , et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging . Am J Cardiol . 1994;128:484–489
  50. Ramani K , Judd RM , Holly TA , et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction . Circulation . 1998;98:2687–2694
  51. Fieno DS , Kim RJ , Chen EL , et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk (Distinction between reversible and irreversible injury throughout infarct healing) . J Am Coll Cardiol . 2000;36:1985–1991
  52. Selvanayagam JB , Kardos A , Francis JM , et al.  Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization . Circulation . 2004;110:1535–1541
  53. Bax JJ , Visser FC , Poldermans D , et al.  Time course of functional recovery of stunned and hibernating segments after surgical revascularization . Circulation . 2001;104:314–318
  54. Bello D , Shah DJ , Farah GM , et al.  Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy . Circulation . 2003;108:1945–1953
  55. Grines CL , Browne KF , Marco J , et al.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction . N Engl J Med . 1993;328:673–679
  56. Kloner RA , Ganote CE , Jennings RB . The “no-reflow” phenomenon after temporary coronary occlusion in the dog . J Clin Invest . 1974;54:1496–1508
  57. Kloner RA , Dai W . Glycoprotein IIb/IIIa inhibitors and no-reflow . J Am Coll Cardiol . 2004;43:284–286
  58. Judd RM , Lugo-Olivieri CH , Arai M , et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of a 2-day-old reperfused canine infarcts . Circulation . 1995;92:1902–1910
  59. Rochitte CE , Lima JAC , Bluemke DA , et al.  Magnitude and time course of microvascular obstruction and tissue injury after myocardial infarction . Circulation . 1998;98:1006–1014
  60. Wu KC , Zerhouni EA , Judd RM , et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction . Circulation . 1998;97:765–772
  61. Bucciarelli-Ducci C , Wu E , Tejedor P , et al.  Hypoenhancement on delayed contrast-enhanced MRI following ST-segment elevation myocardial infarction: an alternate approach for evaluating no-reflow . J Cardiovasc Magn Res . 2005;7:148; [Abstract]
  62. Hombach V , Grebe O , Merkle N , et al.  Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging . Eur Heart J . 2005;26:549–566
  63. Ambrosio G , Weisman HF , Mannisi JA , et al.  Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow . Circulation . 1989;80:1846–1861
  64. Schlegel JU . Demonstration of blood vessels and lymphatics with a fluorescent dye in ultraviolet light . Anat Rec . 1949;105:433–453
  65. Rochitte CE , Kim RJ , Hillebrand HB , et al.  Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction . Circ Res . 2000;87:648–655
  66. The Multicenter Postinfarction Research Group . Risk stratification and survival after myocardial infarction . N Engl J Med . 1983;309:331–336
  67. Volpi A , De Vita C , Franzosi MG , et al.  Determinants of 6-months mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base . Circulation . 1993;88:416–429
  68. Ito H , Tomooka T , Sakai N , et al.  Lack of myocardial perfusion immediately after successful thrombolysis . Circulation . 1992;85:1699–1705
  69. Ito H , Maruyama A , Iwakura K , et al.  Clinical implication of the ‘no-reflow’ phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction . Circulation . 1996;93:223–228
  70. Wu E , Tejedor P , Lee DC , et al.  No reflow detected by delayed contrast enhancment predicts remodeling following an ST-segment myocardial infarction . Circulation . 2004;110: III-444 [abstract]
  71. Gerber BL , Rochitte CE , Melin JA , et al.  Microvascular obstruction and left ventricular remodelling early after acute myocardial infarction . Circulation . 2000;101:2734–2741
  72. Fishbein MC , Y-Rit J , Lando U , et al.  The relationship of vascular injury and myocardial hemorrhage to necrosis alter reperfusion . Circulation . 1980;62:1274–1279
  73. Reffelmann T , Hale SL , Dow JS , et al.  No-reflow phenomenon persists long term after ischemia/reperfusion in the rat and predicts infarct expansion . Circulation . 2003;108:2911–2917
  74. Amado LC , Kraitchman DL , Gerber BL , et al.  Reduction of “no-reflow” phenomenon by intra-aortic balloon conuterpulsation in a randomized magnetic resonance imaging experimental study . J Am Coll Cardiol . 2004;43:1291–1298
  75. Pfeffer MA . Left ventricular remodeling after acute myocardial infarction . Ann Rev Med . 1995;46:455–466
  76. Richard V , Murry CE , Reimer KA . Healing of myocardial infarcts in dogs (Effects of late reperfusion) . Circulation . 1995;92:1891–1901
  77. Reimer KA , Lowe JE , Rasmussen MM , Jennings RB . The wavefront phenomenon of ischemic cell death (Myocardial infarct size vs duration of coronary occlusion in dogs) . Circulation . 1977;56:786–794
  78. Reimer KA , Jennings RB . The changing anatomic reference base of evolving myocardial infarction (Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation) . Circulation . 1979;60:866–876
  79. Fieno DS , Hillebrand HB , Rehwald WG , et al.  Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size . J Am Coll Cardiol . 2004;43:2124–2131
  80. Reimer KA , Jennings RB . The “wavefront phenomenon” of myocardial ischemic cell death, II: transmural progression of necrosis within the framework of ischemic bed size (myocardial at risk) and collateral flow . Lab Invest . 1979;40:633–644
  81. Reimer KA , Lowe JE , Rasmussen MM , et al.  The “wavefront phenomenon” of ischemic cell death, I: myocardial infarct size vs duration of coronary occlusion in dogs . Circulation . 1977;56:786–794
  82. McCrohon JA , Moon JCC , Prasad SK , et al.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance . Circulation . 2003;108:54–59
  83. Roberts WC , Siegel RJ , McManus BM . Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients . Am J Cardiol . 1987;60:1340–1355
  84. Choudhury L , Mahrholdt H , Wagner A , et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy . J Am Coll Cardiol . 2002;40:2156–2164
  85. Maceira AM , Joshi J , Prasad SK , et al.  Cardiovascular magnetic resonance in cardiac amyloidosis . Circulation . 2005;111:186–193
  86. Moon JC , Sachdev B , Elkington AG , et al.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium . Eur Heart J . 2003;24:2151–2155
  87. Moon JC , Mundy HR , Lee PJ , et al.  Myocardial fibrosis in glycogen storage disease type 3 . Circulation . 2003;107:e47
  88. Mahrholdt H , Goedecke C , Wagner A , et al.  Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology . Circulation . 2004;109:1250–1258
  89. Vignaux O . Cardiac sarcoidosis: spectrum of MRI features . AJR Am J Roentgenol . 2005;184:249–254

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(05)00166-0

doi: 10.1016/j.cpcardiol.2005.10.002

Current Problems in Cardiology
Volume 31, Issue 2 , Pages 128-168 , February 2006

Article Tools

* Image Usage & Resolution